sulodexide

Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial

...ral gelcap) PHASE 3 and PHASE 4 CLINICAL PROGRAM sulodexide is in a pivotal Phase 3 and Phase 4 clinical progr... The clinical plan to support an NDA approval for sulodexide under Subpart H (accelerated approval), as agreed ...FDA, as a condition to the accelerated approval of sulodexide based on the Phase 3 clinical trial, that the Phas...

Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data

... No Safety Concerns Raised sulodexide Phase 3 study to continue without modification NEW YORK, Dec. 5 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals (Nasdaq: KERX ) today announced ...

Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois

...ditional abstracts of interest include: 2220 - Oral Administration of sulodexide for the Treatment of Diabetic Nephropathy in a Phase II Study has Mini... AZ, Washington, DC, Baltimore, MD 2376 - Efficacy and Safety of sulodexide in the Treatment of Diabetic Nephropathy RAM WEISS, ROBERT M. NIECEST...

sulodexide in other areas

Sulodexide - Wikipedia, the free encyclopedia

Sulodexide is a highly purified mixture of glycosaminoglycans composed of low molecular weight heparin (80%) and dermatan sulfate (20%).

Sulodexide reduces UAER in DN

: Sulodexide, a low-molecular-weight heparin that can be given orally, is ... The fact that sulodexide is capable of normalizing urine albumin excretion rates ...

Oral Sulodexide Reduces Albuminuria in Microalbuminuric and ...

Sulodexide is a glycosaminoglycan, a new class of drug that has demonstrated ... Treatment with 200 mg/d sulodexide for 4 mo significantly reduced log albumin ...

Sulodexide in the treatment of intermittent claudication. Results of a ...

patients was used to evaluate the usefulness of sulodexide, a ... sulodexide was its thrombogenesis-inhibiting properties, ... allocated to receive sulodexide ...

Effect of Sulodexide in Overt Diabetic Nephropathy - Full Text View ...

Sulodexide belongs to a class of drugs called glycosaminoglycans (GAG) ... Sulodexide is approved in Europe to treat vascular indications. ...

Clinical trial: Sulodexide to Treat Type 2 Diabetic Nephropathy

Sulodexide may protect the kidneys by preventing these chemical changes. ... Prior exposure to sulodexide, either in a clinical setting or as a participant ...